{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:11:03Z","timestamp":1759601463443},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,18]]},"DOI":"10.7759\/cureus.24252","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T23:15:31Z","timestamp":1650323731000},"source":"Crossref","is-referenced-by-count":4,"title":["Neurologic Sequela of COVID-19: Guillain-Barr\u00e9 Syndrome Following Johnson & Johnson COVID-19 Vaccination"],"prefix":"10.7759","author":[{"given":"Octavio","family":"Carranza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Babici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawad","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu H","year":"2020","unstructured":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020, 92:401-2. 10.1002\/jmv.25678","journal-title":"J Med Virol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li H","year":"2020","unstructured":"Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020, 55:105951. 10.1016\/j.ijantimicag.2020.105951","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7352","article-title":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","volume":"12","author":"Filatov A","year":"2020","unstructured":"Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020, 12:e7352. 10.7759\/cureus.7352","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat Z","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020, 76:233-5. 10.1016\/j.jocn.2020.04.062","journal-title":"J Clin Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.025437","article-title":"Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome","volume":"49","author":"Hung EC","year":"2003","unstructured":"Hung EC, Chim SS, Chan PK, et al.. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003, 49:2108-9. 10.1373\/clinchem.2003.025437","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977","volume":"110","author":"Schonberger LB","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al.. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979, 110:105-23. 10.1093\/oxfordjournals.aje.a112795","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","article-title":"Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine","volume":"13","author":"Waheed S","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021, 13:e13426. 10.7759\/cureus.13426","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3619131","article-title":"Exacerbating Guillain-Barr\u00e9 syndrome eight days after vector-based COVID-19 vaccination","volume":"2021","author":"Finsterer J","year":"2021","unstructured":"Finsterer J. Exacerbating Guillain-Barr\u00e9 syndrome eight days after vector-based COVID-19 vaccination. Case Rep Infect Dis. 2021, 2021:3619131. 10.1155\/2021\/3619131","journal-title":"Case Rep Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26279","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response","volume":"28","author":"Hughes DL","year":"2022","unstructured":"Hughes DL, Brunn JA, Jacobs J, Todd PK, Askari FK, Fontana RJ. Guillain-Barr\u00e9 syndrome after COVID-19 mRNA vaccination in a liver transplantation recipient with favorable treatment response. Liver Transpl. 2022, 28:134-7. 10.1002\/lt.26279","journal-title":"Liver Transpl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102540","article-title":"Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar","volume":"67","author":"Razok A","year":"2021","unstructured":"Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Ann Med Surg (Lond). 2021, 67:102540. 10.1016\/j.amsu.2021.102540","journal-title":"Ann Med Surg (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05523-5","article-title":"Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine","volume":"42","author":"Trimboli M","year":"2021","unstructured":"Trimboli M, Zoleo P, Arabia G, Gambardella A. Guillain-Barr\u00e9 syndrome following BNT162b2 COVID-19 vaccine. Neurol Sci. 2021, 42:4401-2. 10.1007\/s10072-021-05523-5","journal-title":"Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243629","article-title":"Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine","volume":"14","author":"Hasan T","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-243629","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244125","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination","volume":"14","author":"McKean N","year":"2021","unstructured":"McKean N, Chircop C. Guillain-Barr\u00e9 syndrome after COVID-19 vaccination. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-244125","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106887","article-title":"Guillain-Barr\u00e9\u00a0syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?","volume":"208","author":"Introna A","year":"2021","unstructured":"Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, Trojano M. Guillain-Barr\u00e9\u00a0syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association?. Clin Neurol Neurosurg. 2021, 208:106887. 10.1016\/j.clineuro.2021.106887","journal-title":"Clin Neurol Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577691","article-title":"Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature","volume":"359","author":"Min YG","year":"2021","unstructured":"Min YG, Ju W, Ha YE, Ban JJ, Lee SA, Sung JJ, Shin JY. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: report of two cases and review of literature. J Neuroimmunol. 2021, 359:577691. 10.1016\/j.jneuroim.2021.577691","journal-title":"J Neuroimmunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.52768\/2766-7820\/1650","article-title":"Neurologic complications of COVID-19 vaccine","volume":"3","author":"Kunal M Ajmera","year":"2022","unstructured":"Kunal M Ajmera, Heather Wilkinson. Neurologic complications of COVID-19 vaccine. J Clin Imag Med Cas Rep. 2022, 3:1650. 10.52768\/2766-7820\/1650","journal-title":"J Clin Imag Med Cas Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.2927","article-title":"The Johnson & Johnson vaccine for COVID-19","volume":"325","author":"Livingston EH","year":"2021","unstructured":"Livingston EH, Malani PN, Creech CB. The Johnson & Johnson vaccine for COVID-19. JAMA. 2021, 325:1575. 10.1001\/jama.2021.2927","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956","article-title":"Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1","volume":"14","author":"Patel SU","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-242956","journal-title":"BMJ Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87625-neurologic-sequela-of-covid-19-guillain-barr-syndrome-following-johnson--johnson-covid-19-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:14Z","timestamp":1707507494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87625-neurologic-sequela-of-covid-19-guillain-barr-syndrome-following-johnson--johnson-covid-19-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.24252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,18]]}}}